Cargando…

Prognostic value of changes in arterial stiffness in men with coronary artery disease

BACKGROUND: Men with coronary artery disease (CAD) have been shown to have enhanced arterial stiffness. Arterial function may change over time according to treatment, but the prognostic value of these changes has not been investigated. OBJECTIVES: The aim of the present study was to assess whether a...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlova, Iana A, Nuraliev, Eradzh Yu, Yarovaya, Elena B, Ageev, Fail T
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988619/
https://www.ncbi.nlm.nih.gov/pubmed/21127698
http://dx.doi.org/10.2147/VHRM.S13591
_version_ 1782192256864747520
author Orlova, Iana A
Nuraliev, Eradzh Yu
Yarovaya, Elena B
Ageev, Fail T
author_facet Orlova, Iana A
Nuraliev, Eradzh Yu
Yarovaya, Elena B
Ageev, Fail T
author_sort Orlova, Iana A
collection PubMed
description BACKGROUND: Men with coronary artery disease (CAD) have been shown to have enhanced arterial stiffness. Arterial function may change over time according to treatment, but the prognostic value of these changes has not been investigated. OBJECTIVES: The aim of the present study was to assess whether an improvement in large artery rigidity in response to treatment, could predict a more favorable prognosis in a population of men with CAD. METHODS: A total of 161 men with CAD (mean age 56.8 ± 10.9 years) being treated with conventional therapy underwent brachial-ankle pulse wave velocity (PWVba) measurements at baseline and after six months. Follow-up period was 3.5 years. End-points were major adverse cardiac events (MACE): acute myocardial infarction, unstable angina, coronary intervention, or cardiac death. RESULTS: During the three-year follow-up period (since initial six-month follow-up), 30 patients experienced MACE. After six-month follow-up, PWVba had not improved (ΔPWVba ≥ 0%, relative to baseline) in 85 (52.8%) of 161 men (Group 1), whereas it had improved (ΔPWVba < 0%) in the remaining 76 men (47.2%) (Group 2). During follow-up, we noticed 24 cardiovascular events in Group 1 and six events in Group 2 (P < 0.001). Cox proportional hazards analyses demonstrated that independent of conventional risk factor changes, absence of PWVba decrease was a predictor of MACE (RR 3.99; 95% CI:1.81–8.78; P = 0.004). The sensitivity of ΔPWVba was 80% and its specificity was 54%. CONCLUSIONS: This study demonstrates that an improvement in arterial stiffness may be obtained after six months of conventional therapy and clearly identifies patients who have a more favorable prognosis.
format Text
id pubmed-2988619
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-29886192010-12-02 Prognostic value of changes in arterial stiffness in men with coronary artery disease Orlova, Iana A Nuraliev, Eradzh Yu Yarovaya, Elena B Ageev, Fail T Vasc Health Risk Manag Original Research BACKGROUND: Men with coronary artery disease (CAD) have been shown to have enhanced arterial stiffness. Arterial function may change over time according to treatment, but the prognostic value of these changes has not been investigated. OBJECTIVES: The aim of the present study was to assess whether an improvement in large artery rigidity in response to treatment, could predict a more favorable prognosis in a population of men with CAD. METHODS: A total of 161 men with CAD (mean age 56.8 ± 10.9 years) being treated with conventional therapy underwent brachial-ankle pulse wave velocity (PWVba) measurements at baseline and after six months. Follow-up period was 3.5 years. End-points were major adverse cardiac events (MACE): acute myocardial infarction, unstable angina, coronary intervention, or cardiac death. RESULTS: During the three-year follow-up period (since initial six-month follow-up), 30 patients experienced MACE. After six-month follow-up, PWVba had not improved (ΔPWVba ≥ 0%, relative to baseline) in 85 (52.8%) of 161 men (Group 1), whereas it had improved (ΔPWVba < 0%) in the remaining 76 men (47.2%) (Group 2). During follow-up, we noticed 24 cardiovascular events in Group 1 and six events in Group 2 (P < 0.001). Cox proportional hazards analyses demonstrated that independent of conventional risk factor changes, absence of PWVba decrease was a predictor of MACE (RR 3.99; 95% CI:1.81–8.78; P = 0.004). The sensitivity of ΔPWVba was 80% and its specificity was 54%. CONCLUSIONS: This study demonstrates that an improvement in arterial stiffness may be obtained after six months of conventional therapy and clearly identifies patients who have a more favorable prognosis. Dove Medical Press 2010 2010-11-04 /pmc/articles/PMC2988619/ /pubmed/21127698 http://dx.doi.org/10.2147/VHRM.S13591 Text en © 2010 Orlova et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Orlova, Iana A
Nuraliev, Eradzh Yu
Yarovaya, Elena B
Ageev, Fail T
Prognostic value of changes in arterial stiffness in men with coronary artery disease
title Prognostic value of changes in arterial stiffness in men with coronary artery disease
title_full Prognostic value of changes in arterial stiffness in men with coronary artery disease
title_fullStr Prognostic value of changes in arterial stiffness in men with coronary artery disease
title_full_unstemmed Prognostic value of changes in arterial stiffness in men with coronary artery disease
title_short Prognostic value of changes in arterial stiffness in men with coronary artery disease
title_sort prognostic value of changes in arterial stiffness in men with coronary artery disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988619/
https://www.ncbi.nlm.nih.gov/pubmed/21127698
http://dx.doi.org/10.2147/VHRM.S13591
work_keys_str_mv AT orlovaianaa prognosticvalueofchangesinarterialstiffnessinmenwithcoronaryarterydisease
AT nuralieveradzhyu prognosticvalueofchangesinarterialstiffnessinmenwithcoronaryarterydisease
AT yarovayaelenab prognosticvalueofchangesinarterialstiffnessinmenwithcoronaryarterydisease
AT ageevfailt prognosticvalueofchangesinarterialstiffnessinmenwithcoronaryarterydisease